While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in ...

Artificial intelligence (AI) is on pace to become the most rapidly adopted technology in health care, 1 whether clinicians are ready for it or not. From ambient scribes transcribing doctor-patient ...

Among issues highlighted are that many patients don’t feel heard and need to improve discharge protocols in emergency rooms ...

New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer. Ozempic, the cancer ...

South Africa has the world’s largest population of people living with HIV, which both heightens the risk of anal cancers and ...

October is Breast Cancer Awareness Month, and this weekend was the Susan G. Komen three-day walk, a massive fundraiser for breast cancer research and support. Sunday, nearly 600 walkers took off from ...

Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Nagpur: The Nagpur bench of the Bombay High Court on Monday directed the Maharashtra government to explain why eight shelters ...

IT’S something we are all guilty of – dismissing symptoms as ‘nothing to worry about’ or something that can be left for now.